C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2011
03/24/2011	US20110070653 INHIBITOR OF HISTONE ACETYLTRANSFERASE, ESPECIALLY p300
03/24/2011	US20110070652 Phage microarray profiling of the humoral response to disease
03/24/2011	US20110070649 Method for manufacturing glycoproteins having human-type glycosylation
03/24/2011	US20110070620 Substrates comprising switchable ferromagnetic nanoparticles
03/24/2011	US20110070616 Production of itaconic acid
03/24/2011	US20110070614 Fucose transporter
03/24/2011	US20110070608 Method for Producing Corn Gluten Hydrolysate and Corn Gluten Hydrolysate Using the Same
03/24/2011	US20110070605 Reversible mhc multimer staining for functional purification of antigen-specific t cells
03/24/2011	US20110070591 Replication protein
03/24/2011	US20110070440 Artificial Organelle On A Digital Microfluidic Chip Used To Redesign The Biological Activities of Heparan Sulfate
03/24/2011	US20110070276 Bioactive keratin peptides
03/24/2011	US20110070268 Method
03/24/2011	US20110070267 Packaged virus-like particles for use as adjuvants: method of preparation and use
03/24/2011	US20110070265 Engineered pertactin variants for vaccine use
03/24/2011	US20110070257 Polyvalent Chimeric OSPC Vaccinogen and Diagnostic Antigen
03/24/2011	US20110070256 Vaccine Antigens from Piscirickettsia Salmonis
03/24/2011	US20110070255 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
03/24/2011	US20110070254 Mutations in the influenza a virus ns1 gene and use thereof
03/24/2011	US20110070253 Tumour-associated peptides binding to mhc molecules
03/24/2011	US20110070252 Mage-a3/hpv 16 peptide vaccines for head and neck cancer
03/24/2011	US20110070251 Cancer vaccine composition
03/24/2011	US20110070249 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN
03/24/2011	US20110070234 Np1 activity regulating elements useful for the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof
03/24/2011	US20110070208 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof
03/24/2011	US20110070195 Uses of spatial configuration to modulate protein function
03/24/2011	US20110070191 T cell receptor fusions and conjugates and methods of use there of
03/24/2011	US20110070184 Methods and compositions for treating atherosclerosis and related condidtions
03/24/2011	US20110070155 Anti-CD74 Immunoconjugates and Methods
03/24/2011	CA2811072A1 Universal fibronectin type iii binding-domain libraries
03/24/2011	CA2780512A1 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development
03/24/2011	CA2774640A1 Virus like particles comprising target proteins fused to plant viral coat proteins
03/24/2011	CA2774456A1 Cloning and exploitation of a functional r-gene from solanum chacoense
03/24/2011	CA2774350A1 Novel peptides isolated from spider venom, and uses thereof
03/24/2011	CA2774333A1 Fusion polypeptides and uses thereof
03/24/2011	CA2774212A1 Protein a crystals and cross-linked crystals and methods of use thereof
03/24/2011	CA2774154A1 Immunological compositions for hiv
03/24/2011	CA2774024A1 Buffers for controlling the ph of bone morphogenetic proteins
03/24/2011	CA2773935A1 Peptides for the treatment of oxidative stress related disorders
03/24/2011	CA2773731A1 Canola protein product from supernatant
03/24/2011	CA2773488A1 Inhibition of bolting and flowering of a sugar beet plant
03/23/2011	EP2299269A1 Protein fragment complementation assay based on beta-lactamase
03/23/2011	EP2298934A1 S. pneumoniae antigens
03/23/2011	EP2298927A2 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
03/23/2011	EP2298926A1 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
03/23/2011	EP2298924A2 Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
03/23/2011	EP2298922A1 Amino acid and nucleic acid sequences for controlling pathogens
03/23/2011	EP2298920A1 Plants having increased yield and a method for making the same
03/23/2011	EP2298919A1 Method to increase stress tolerance in plants
03/23/2011	EP2298918A2 Regulation of Plant Biomass and Stress Tolerance
03/23/2011	EP2298915A1 Methods of protecting plants from pathogenic fungi
03/23/2011	EP2298914A1 Methods of protecting plants from pathogenic fungi
03/23/2011	EP2298910A1 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
03/23/2011	EP2298900A1 Compositions and methods for treating intracellular diseases
03/23/2011	EP2298899A2 CRSP proteins (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
03/23/2011	EP2298890A1 Chinese hamster apoptosis-related genes
03/23/2011	EP2298889A1 Chinese hamster apoptosis-related genes
03/23/2011	EP2298888A1 Chinese hamster apoptosis-related genes
03/23/2011	EP2298887A1 Chinese hamster apoptosis-related genes
03/23/2011	EP2298878A2 Compositions and methods for the diagnosis of cancer
03/23/2011	EP2298877A1 Compounds for immunotherapy of prostate cancer and methods for their use
03/23/2011	EP2298875A2 Variants with altered properties
03/23/2011	EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them
03/23/2011	EP2298816A2 Apoptosis induced by an antibody against Her2
03/23/2011	EP2298814A2 Method for quantifying phosphokinase activity on proteins
03/23/2011	EP2298808A1 Anti-C5 antibodies and their therapeutic uses
03/23/2011	EP2298803A2 Human G-protein coupled receptor and ligands thereof
03/23/2011	EP2298802A1 T1R3 taste receptors and genes encoding same
03/23/2011	EP2298801A1 Glycosylated glp-1 peptide
03/23/2011	EP2298800A1 Sclerostin binding antibodies
03/23/2011	EP2298799A1 A gene encoding a multidrug resistance human p-glyoprotein homologue on chromosome 7p15-21 and uses thereof
03/23/2011	EP2298798A1 Identification and characterization of a novel avian pathogenic E. coli (APEC) fimbrial adhesin
03/23/2011	EP2298797A2 Increased bacillus YweA expression
03/23/2011	EP2298796A2 Staphylococcus aureus proteins and nucleic acids
03/23/2011	EP2298795A1 Immunogens from uropathogenic escherichia coli
03/23/2011	EP2298794A2 Chimeric vaccine for haemophilus influenzae-induced disease
03/23/2011	EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits
03/23/2011	EP2298792A2 Peptides targeted to protein kinase C isoforms and uses thereof
03/23/2011	EP2298791A1 Binding molecules for human factor VIII and factor VIII-like proteins
03/23/2011	EP2298789A1 Mammalian genes; related reagents and methods
03/23/2011	EP2298736A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
03/23/2011	EP2298357A1 Compositions and methods for regulated protein expression in gut
03/23/2011	EP2298355A2 Albumin fusion proteins
03/23/2011	EP2298354A2 Remodelling and glycoconjugation of interferon-beta
03/23/2011	EP2298345A2 Specific binding members for NGF
03/23/2011	EP2298342A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
03/23/2011	EP2298338A1 Lactoferrin compositions and methods of treatment of skin wounds
03/23/2011	EP2298337A2 Regulation of food preference using GLP-1 agonists
03/23/2011	EP2298334A2 Tweak receptor
03/23/2011	EP2298333A2 Tweak receptor
03/23/2011	EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response
03/23/2011	EP2298331A2 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
03/23/2011	EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO)
03/23/2011	EP2298278A1 Prevention and reduction of blood loss
03/23/2011	EP2298067A1 Novel pesticidal toxins
03/23/2011	EP2297334A1 Biomarker for assessing response to chymase treatment
03/23/2011	EP2297327A1 Plants having enhanced yield-related traits and a method for making the same
03/23/2011	EP2297325A1 Methods of stratifying, prognosing and diagnosing schizophrenia, mutant nucleic acid molecules and polypeptides
03/23/2011	EP2297309A1 Pestivirus replicons providing an rna-based viral vector system
03/23/2011	EP2297199A1 Interleukin-21 receptor binding proteins
03/23/2011	EP2297198A1 Fn14/trail fusion proteins

1 ... 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 ... 2916